港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

醫藥外包概念

2,217.549

-44.854-1.98%

漲家數：- -

跌家數：8

平家數：- -

市盈率：- -

高：2,276.820

開：2,262.471

低：2,193.695

收：2,262.402

資料載入中...

康龍化成員工互毆出圈，股東更狠：上市6年狂減215億！

港交所消息：7月11日，花旗集團持有的藥明生物H股多頭頭寸從3.99%增至5.49%

復星醫藥(02196.HK)自研新藥XH-S004在內地治療COPD啓動Ib期臨牀試驗

阿斯达克财经

泰格醫藥：出售參股公司禮新醫藥股權

泰格醫藥美國團隊助力全球首款AI原發性震顫治療設備獲FDA批准

【恆瑞醫藥(01276.HK)：SHR-8068 注射液獲批開展臨牀試驗】智通財經APP訊，恆瑞醫藥(01276.HK)

恆瑞醫藥(600276.SH)：SHR-8068注射液藥物臨牀試驗獲批准

恆瑞醫藥：獲得四項藥物臨牀試驗批准通知書

中牧股份：收到非洲豬瘟亞單位疫苗臨牀試驗批件

昭衍新藥07月17日獲主力加倉1001.0萬元

中牧股份(600195.SH)獲得非洲豬瘟亞單位疫苗臨牀試驗批件

康龍化成07月17日主力淨流入731.4萬元散户資金拋售

三葉草生物-B尾盤漲超38% 近期啓動呼吸道聯合疫苗候選產品I期臨牀試驗

研報掘金丨中金：康龍化成主營業務持續向好，維持A/H股“跑贏行業”評級

研報掘金丨華鑫證券：予眾生藥業“買入”評級，業績增長恢復，關注GLP-1的對外授權

創新藥再獲熱炒恒生醫療ETF漲4.37% 樂普生物(02157)漲兩成機構稱價值重估驅動行情

BUZZ-GenScript 生物技術公司因聯營公司 Carvykti 銷售業績超預期而大漲

維亞生物盤中異動急速拉昇5.23%報1.610港元

【港股異動 | 金斯瑞生物科技(01548.HK)現漲超6% 第二季CARVYKTI銷售額同比增長約1.36倍】智通財經

金斯瑞生物科技盤中異動股價大漲5.07%報16.160港元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1576/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1576","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1576\",,,,,undefined,":{"symbol":"BK1576","market":"HK","secType":"PLATE","nameCN":"醫藥外包概念","latestPrice":2217.5486,"timestamp":1753085317147,"preClose":2262.4023,"halted":0,"volume":92790953,"delay":0,"changeRate":-0.019826,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盤","change":-44.85376,"latestTime":"07-21 16:00:00","open":2262.471,"high":2276.8196,"low":2193.695,"amount":2444384021,"amplitude":0.036742,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1753147800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1753061400000,1753070400000],[1753074000000,1753084800000]],"pbRate":2.678209,"peRate":12.781827,"turnoverRate":0.008008,"increases":0,"decrements":8,"flats":0,"marketCap":508098054144,"floatMarketCap":204119770880},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1576\",,,,,undefined,":{"symbol":"BK1576","high":2276.8196,"amplitude":0.036742,"preClose":2262.4023,"low":2193.695,"pbRate":"2.678209","latestPrice":2217.5486,"volume":92790953,"delay":0,"open":2262.471,"prevYearClose":1395.7731,"prevWeekClose":2262.402,"prevMonthClose":1988.255,"prevQuarterClose":1988.255,"fiveDayClose":2114.666,"twentyDayClose":1883.162,"sixtyDayClose":1645.051,"secType":"PLATE","market":"HK","turnoverRate":0.008008,"peRate":12.781827,"marketCap":508098054144,"floatMarketCap":204119770880,"timestamp":1753085317147,"nameCN":"醫藥外包概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1576\",,,,undefined,":{"bkCode":"BK1576","up":0,"down":8,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1576\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2552843657","title":"康龍化成員工互毆出圈，股東更狠：上市6年狂減215億！","url":"https://stock-news.laohu8.com/highlight/detail?id=2552843657","media":"市场资讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552843657?lang=zh_tw&edition=fundamental","pubTime":"2025-07-17 18:10","pubTimestamp":1752747000,"startTime":"0","endTime":"0","summary":"净利润的波动则要更剧烈一些，2022年扣非净利润增速直接由67.5%降至个位数，2024年更是直接负增长，扣非净利润同比下滑26.8%，达11.1亿。不过有个数据，风云君还是要强调下，自康龙化成上市以来，无论是实控人、股东、高管，还是上市前的投资机构都在持续减持。根据choice统计的数据，上述重要股东上市以来A股市场已累计减持套现214.53亿。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717182134a450df57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717182134a450df57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03759","BK1141","BK1576"],"gpt_icon":0},{"id":"2552645433","title":"港交所消息：7月11日，花旗集團持有的藥明生物H股多頭頭寸從3.99%增至5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552645433","media":"新浪财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552645433?lang=zh_tw&edition=fundamental","pubTime":"2025-07-17 17:44","pubTimestamp":1752745456,"startTime":"0","endTime":"0","summary":"港交所消息：7月11日，花旗集团持有的 药明生物 H股多头头寸从3.99%增至5.49%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717175143a450cd0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717175143a450cd0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999002562.SGD","LU0572944931.SGD","LU0516423091.SGD","LU2039709279.SGD","LU0417516738.SGD","SG9999002463.SGD","LU0456846285.SGD","LU0043850808.USD","BK1521","LU0140636845.USD","BK1576","LU0856984785.SGD","LU0979878070.USD","LU0348825331.USD","LU0417516902.SGD","LU0823426308.USD","LU0708995583.HKD","LU1688375341.USD","LU0516422952.EUR","BK1141","LU0588546209.SGD","LU1794554557.SGD","LU0359201612.USD","IE00B0JY6N72.USD","BK1610","LU0823426480.USD","LU0181495838.USD","LU0051755006.USD","LU0320764599.SGD","LU0516423174.USD","LU1880383366.USD","LU0516422440.USD","LU0456827905.SGD","BK1589","LU0819121731.USD","LU0516422366.SGD","LU0327786744.USD","02269","LU0039217434.USD","LU1242518857.USD","LU0307460666.USD","LU1242518931.SGD","LU0326950275.SGD","LU0348735423.USD","LU1720050803.USD","LU0052750758.USD","LU0359202008.SGD"],"gpt_icon":0},{"id":"2552881214","title":"復星醫藥(02196.HK)自研新藥XH-S004在內地治療COPD啓動Ib期臨牀試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2552881214","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552881214?lang=zh_tw&edition=fundamental","pubTime":"2025-07-17 17:44","pubTimestamp":1752745440,"startTime":"0","endTime":"0","summary":"复星医药(02196.HK) 公布，控股子公司星浩澎博自主研发的1类新药XH-S004用于治疗慢性阻塞性肺疾病(COPD)适应症于近日在中国境内(不包括港澳台地区)启动Ib期临床试验。公司指，XH-S004为复星医药自主研发的小分子口服二肽基肽酶1(DPP-1)抑制剂，拟用于治疗COPD、非囊性纤维化支气管扩张症等。XH-S004 另一适应症用于治疗非囊性纤维化支气管扩张症在中国境内处于II期临床试验阶段。(ss/u)(港股报价延迟最少十五分钟。沽空资料截至 2025-07-17 16:25。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220221174704291_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220221174704291_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1454239/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK0187","BK0239","BK1191","03347","BK0060","BK0183","BK0012","600196","BK0196","BK0188","BK1583","02196","BK0175","BK0028","BK0096","BK1593","BK1141","BK1515","BK1576"],"gpt_icon":0},{"id":"2552606107","title":"泰格醫藥：出售參股公司禮新醫藥股權","url":"https://stock-news.laohu8.com/highlight/detail?id=2552606107","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552606107?lang=zh_tw&edition=fundamental","pubTime":"2025-07-17 17:09","pubTimestamp":1752743344,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0216","BK1576","BK1515","BK0174","300347","BK1583","BK0077","03347","BK1191","01477","BK0028","BK1574","LU1146622755.USD","LU1820825898.SGD","09939","BK1161","BK1141","159938"],"gpt_icon":0},{"id":"2552489435","title":"泰格醫藥美國團隊助力全球首款AI原發性震顫治療設備獲FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2552489435","media":"泰格医药","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552489435?lang=zh_tw&edition=fundamental","pubTime":"2025-07-17 17:01","pubTimestamp":1752742862,"startTime":"0","endTime":"0","summary":"2025年7月，神经AI技术领域的领军企业Fasikl公司宣布，其自主研发的Felix NeuroAI腕带已获得美国食品药品监督管理局批准，用于治疗成人原发性震颤引起的上肢功能障碍。Felix 腕带是全球首款且唯一获得FDA批准、基于人工智能的原发性震颤治疗设备，开创了AI治疗新时代。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717180713a6af8bf8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717180713a6af8bf8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1141","03347","BK1576"],"gpt_icon":0},{"id":"2552102695","title":"【恆瑞醫藥(01276.HK)：SHR-8068 注射液獲批開展臨牀試驗】智通財經APP訊，恆瑞醫藥(01276.HK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2552102695","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552102695?lang=zh_tw&edition=fundamental","pubTime":"2025-07-17 16:55","pubTimestamp":1752742535,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2488822045.USD","03347","BK0028","BK1141","LU1997245177.USD","600276","LU1655091616.SGD","BK1191","BK0239","LU0405327148.USD","BK1583","BK0188","BK0196","LU1064130708.USD","01276","LU1328615791.USD","BK0012","LU1969619763.USD","BK0060","LU1064131003.USD","LU0405327494.USD","LU2495084118.USD","399441","LU1997244956.HKD","LU1997245094.SGD","LU2148510915.USD","LU2328871848.SGD","161726","BK0183","BK1576"],"gpt_icon":0},{"id":"2552327102","title":"恆瑞醫藥(600276.SH)：SHR-8068注射液藥物臨牀試驗獲批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2552327102","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552327102?lang=zh_tw&edition=fundamental","pubTime":"2025-07-17 16:48","pubTimestamp":1752742104,"startTime":"0","endTime":"0","summary":"智通财经APP讯，恒瑞医药(600276.SH)公告，公司子公司苏州盛迪亚生物医药有限公司收到国家药品监督管理局核准签发关于SHR-8068注射液的《药物临床试验批准通知书》，本品将联合阿美替尼在晚期非小细胞肺癌患者中开展临床试验。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1318971.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0405327494.USD","LU1997245094.SGD","LU1969619763.USD","LU1064130708.USD","LU2148510915.USD","LU1997245177.USD","03347","LU0405327148.USD","LU1064131003.USD","BK1141","BK0239","BK0012","01276","LU1328615791.USD","LU2488822045.USD","BK0028","BK0060","LU1655091616.SGD","BK1191","BK0183","BK1576","BK0196","LU2328871848.SGD","BK0188","LU1997244956.HKD","BK1583","LU2495084118.USD","600276"],"gpt_icon":0},{"id":"2552104266","title":"恆瑞醫藥：獲得四項藥物臨牀試驗批准通知書","url":"https://stock-news.laohu8.com/highlight/detail?id=2552104266","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552104266?lang=zh_tw&edition=fundamental","pubTime":"2025-07-17 16:35","pubTimestamp":1752741300,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1969619763.USD","BK0060","600276","BK1576","LU1997244956.HKD","LU1169590202.USD","LU2148510915.USD","PD","BK1583","BK0188","BK4023","BK0239","BK0183","LU1997245094.SGD","LU1328615791.USD","LU1655091616.SGD","BK0028","LU1169589451.USD","LU1997245177.USD","LU0405327494.USD","LU0405327148.USD","LU1064130708.USD","BK1141","LU2488822045.USD","01276","LU2495084118.USD","BK1191","LU1064131003.USD","03347","LU2328871848.SGD","BK0012","BK0196"],"gpt_icon":0},{"id":"2552104380","title":"中牧股份：收到非洲豬瘟亞單位疫苗臨牀試驗批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2552104380","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552104380?lang=zh_tw&edition=fundamental","pubTime":"2025-07-17 16:19","pubTimestamp":1752740348,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1141","BK1576","600195","BK1583","BK0168","BK0010","BK0046","03347","BK0239","BK0028","159646"],"gpt_icon":0},{"id":"2552643877","title":"昭衍新藥07月17日獲主力加倉1001.0萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552643877","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552643877?lang=zh_tw&edition=fundamental","pubTime":"2025-07-17 16:15","pubTimestamp":1752740156,"startTime":"0","endTime":"0","summary":"07月17日, 昭衍新药股价涨5.85%，报收21.70元，成交金额1.7亿元，换手率6.56%，振幅9.27%，量比0.81。昭衍新药今日主力资金净流入1001.0万元，上一交易日主力净流入961.5万元。该股近5个交易日上涨9.56%，主力资金累计净流入1861.6万元；近20日主力资金累计净流入2033.7万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717172021a6af7075&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717172021a6af7075&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1576","06127"],"gpt_icon":0},{"id":"2552775101","title":"中牧股份(600195.SH)獲得非洲豬瘟亞單位疫苗臨牀試驗批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2552775101","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552775101?lang=zh_tw&edition=fundamental","pubTime":"2025-07-17 16:15","pubTimestamp":1752740147,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中牧股份(600195.SH)发布公告，近日，公司收到了农业农村部颁发的非洲猪瘟亚单位疫苗临床试验批件(批件号：2025058)。非洲猪瘟亚单位疫苗用于预防非洲猪瘟病毒感染，公司于2023年与科研院所合作研究开发该疫苗。截至目前，该产品累计研发投入金额约为人民币4,624.46万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1318942.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03347","BK0239","BK1141","BK0010","BK1576","BK0028","BK0168","BK1583","BK0046","600195","159646"],"gpt_icon":0},{"id":"2552943872","title":"康龍化成07月17日主力淨流入731.4萬元 散户資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2552943872","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552943872?lang=zh_tw&edition=fundamental","pubTime":"2025-07-17 16:15","pubTimestamp":1752740145,"startTime":"0","endTime":"0","summary":"07月17日, 康龙化成股价涨3.95%，报收18.44元，成交金额2.7亿元，换手率5.12%，振幅3.95%，量比0.93。康龙化成今日主力资金净流入731.4万元，上一交易日主力净流出1662.0万元。该股近5个交易日上涨8.75%，主力资金累计净流入1.1亿元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入1.2亿元，其中净流入天数为10日。该股主力净额占比0.14%，港股市场排名96/2671。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717171612a6af6cf7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717171612a6af6cf7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1576","03759"],"gpt_icon":0},{"id":"2552533435","title":"三葉草生物-B尾盤漲超38% 近期啓動呼吸道聯合疫苗候選產品I期臨牀試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2552533435","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552533435?lang=zh_tw&edition=fundamental","pubTime":"2025-07-17 15:55","pubTimestamp":1752738908,"startTime":"0","endTime":"0","summary":"三叶草生物-b(02197)尾盘涨超38%，截至发稿，涨35.21%，报0.48港元，成交额1515.74万港元。消息面上，三叶草生物上月宣布，一项评估SCB-1022(RSV+hMPV)及SCB1033(RSV+hMPV+PIV3)呼吸道联合疫苗候选产品的I期临床试验已完成首批受试者入组。该等疫苗候选产品开发的融合前稳定的F(PreF)三聚体亚单位疫苗抗原基于三叶草生物的蛋白质三聚体化疫苗技术平台。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717161257a6af3fd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717161257a6af3fd0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02197","BK1141","BK1576","03347","BK1161","BK1583"],"gpt_icon":0},{"id":"2552649109","title":"研報掘金丨中金：康龍化成主營業務持續向好，維持A/H股“跑贏行業”評級","url":"https://stock-news.laohu8.com/highlight/detail?id=2552649109","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552649109?lang=zh_tw&edition=fundamental","pubTime":"2025-07-17 15:38","pubTimestamp":1752737886,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["159982","161631","BK1141","03759","BK0216","BK1576","CDMO","300759","399300","BK4139"],"gpt_icon":0},{"id":"2552010534","title":"研報掘金丨華鑫證券：予眾生藥業“買入”評級，業績增長恢復，關注GLP-1的對外授權","url":"https://stock-news.laohu8.com/highlight/detail?id=2552010534","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552010534?lang=zh_tw&edition=fundamental","pubTime":"2025-07-17 14:21","pubTimestamp":1752733313,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1583","BK4585","BK4139","BK4590","BK1141","BK1161","GLP","159992","BK1576","RNA","BK4505","002317","BK1574","BK0239","BK4144","06978","03347","BK0077","BK0188","BK4588","161027"],"gpt_icon":0},{"id":"2552058901","title":"創新藥再獲熱炒 恒生醫療ETF漲4.37% 樂普生物(02157)漲兩成 機構稱價值重估驅動行情","url":"https://stock-news.laohu8.com/highlight/detail?id=2552058901","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552058901?lang=zh_tw&edition=fundamental","pubTime":"2025-07-17 14:08","pubTimestamp":1752732500,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药再获热炒，恒生医疗ETF暂涨4.37%，乐普生物-B 涨20.55%，康诺亚-B涨14.7%，康方生物涨11.75%，三生制药涨11.09%，百济神州涨10.02%，科伦博泰生物-B涨9.29%，金斯瑞生物科技涨8.45%，先声药业涨8.44%。国家医保局于本周二宣布启动第11轮国家药品集采，涉及55种药品。医院需在7月16日至7月31日期间报告采购量。值得注意的是，《通知》首次附上了68种符合评价标准但未纳入第11批VBP的产品名单，并具体说明了排除原因。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/OTEzM2QyMzQzMjc2MzA3OTk2MA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OTEzM2QyMzQzMjc2MzA3OTk2MA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1962441","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B5MMRT66.SGD","06160","LU2328871848.SGD","BK1583","513060","BK1500","09926","LU0417516571.SGD","BK1141","BK1161","LU0196878994.USD","LU0348784397.USD","HK0000306701.USD","BK1574","BK1593","02162","LU1720050803.USD","06978","01548","02157","HK0000320264.USD","IE00BPRC5H50.USD","LU1969619763.USD","LU1794554557.SGD","BK1576","06990","HK0000306685.HKD","LU0588546209.SGD","LU0307460666.USD","BK1587","LU2488822045.USD","01530","BK1191","LU0348783233.USD","HK0000320223.HKD","IE00B543WZ88.USD","02096","159992","BK1588"],"gpt_icon":0},{"id":"2552170546","title":"BUZZ-GenScript 生物技術公司因聯營公司 Carvykti 銷售業績超預期而大漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2552170546","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552170546?lang=zh_tw&edition=fundamental","pubTime":"2025-07-17 12:17","pubTimestamp":1752725832,"startTime":"0","endTime":"0","summary":"7月17日 - ** GenScript生物科技公司1548.HK股价跳升7.3%至16.5港元，为6月16日以来最高，并将连续第五个交易日上涨** 股价有望创6月9日以来最大单日涨幅** 在香港上市的GenScript称， ，其联营公司联想生物LEGN.O宣布，其癌症治疗药物Carvykti在截至6月底的季度里实现了约4.39亿美元的净销售额。** 截至目前，GenScript 的股价上涨了 66.3 (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nL4S3TE09N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","LU1023059063.AUD","LU0345770993.USD","LEGN","BK4532","LU1894683348.USD","01548","LU0203345920.USD","LU1280957306.USD","IE00B19Z3B42.SGD","IE00BVYPNV92.GBP","BK4559","IE0002270589.USD","LU0345769128.USD","LU0882574055.USD","LU1059921491.USD","LU2505996681.GBP","HK0000320223.HKD","LU2129689431.USD","SG9999002224.SGD","LU1778281490.HKD","IE0009355771.USD","LU1585245621.USD","BK1576","IE00B3PB1722.GBP","LU0795875086.SGD","BK4568","IE00B42XCP33.USD","LU2112291526.USD","IE00BJT1NW94.SGD","BK4581","BK4592","LU1066051498.USD","LU0345770308.USD","LU1032466523.USD","LU1066053197.SGD","JNJ","LU2089984988.USD","LU1032955483.USD","BK4139","BK4588","IE00BFXG1179.USD","LU1066051811.HKD","IE00B19Z3581.USD","LU2430703095.HKD","LU2602419157.SGD","IE00BN8TJ469.HKD","LU0122379950.USD","LU1244550494.USD","IE00B2B36J28.USD"],"gpt_icon":0},{"id":"2552655109","title":"維亞生物盤中異動 急速拉昇5.23%報1.610港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552655109","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552655109?lang=zh_tw&edition=fundamental","pubTime":"2025-07-17 11:50","pubTimestamp":1752724212,"startTime":"0","endTime":"0","summary":"2025年07月17日临近午盘11时50分，维亚生物股票出现波动，股价大幅上涨5.23%。截至发稿，该股报1.610港元/股，成交量480.5万股，换手率0.23%，振幅4.58%。资金方面，该股资金流入513.543万港元，流出218.762万港元。维亚生物股票所在的生物技术行业中，整体涨幅为6.15%。其相关个股中，三叶草生物-B、复旦张江、乐普生物-B涨幅较大，振幅较大的相关个股有复旦张江、三叶草生物-B、乐普生物-B，振幅分别为34.81%、30.99%、14.68%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717115012a6aec8f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717115012a6aec8f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1141","01873"],"gpt_icon":0},{"id":"2552817739","title":"【港股異動 | 金斯瑞生物科技(01548.HK)現漲超6% 第二季CARVYKTI銷售額同比增長約1.36倍】智通財經","url":"https://stock-news.laohu8.com/highlight/detail?id=2552817739","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552817739?lang=zh_tw&edition=fundamental","pubTime":"2025-07-17 11:11","pubTimestamp":1752721872,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01548","HK0000320223.HKD","HK0000306685.HKD","BK1141","HK0000306701.USD","BK1583","HK0000320264.USD","BK1576"],"gpt_icon":0},{"id":"2552108076","title":"金斯瑞生物科技盤中異動 股價大漲5.07%報16.160港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552108076","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552108076?lang=zh_tw&edition=fundamental","pubTime":"2025-07-17 10:57","pubTimestamp":1752721048,"startTime":"0","endTime":"0","summary":"2025年07月17日早盘10时57分，金斯瑞生物科技股票出现异动，股价大幅上涨5.07%。金斯瑞生物科技股票所在的生物技术行业中，整体涨幅为6.06%。消息层面，截至10时57分，《执行董事孟建革减持金斯瑞生物科技约74.33万股 每股作价约15.21港元》资讯为影响金斯瑞生物科技的重要信息。该信息摘要如下：7月9日，执行董事孟建革减持金斯瑞生物科技74.3320万股，每股作价15.211港元，总金额约为1130.66万港元。减持后最新持股数目约为40.07万股，持股比例为0.02%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717105728a6aeaf74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717105728a6aeaf74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","01548","HK0000306685.HKD","HK0000320223.HKD","HK0000306701.USD","BK1576","BK1583","HK0000320264.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":13,"pageCount":3,"totalSize":242,"code":"91000000","status":"200"}]}}